致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human TNFRSF12A/TWEAKR, hFc-tag
目录号 NBL-241999
别名 TNFRSF12A/TWEAKR; FGF-inducible 14; Fgfrp2; TNFRSF12A; FN14; CD266; TWEAKR
外观 see COA
分子量 Glu28-Per80
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 Q9NP84-1
备注2
目录号 规格 价格 库存状态  
NBL-241999-100ug 100ug Inquire Inquire
NBL-241999-1mg 1mg Inquire Inquire
NBL-241999-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human TNFRSF12A/TWEAKR, hFc-tag


Catalog#:

NBL-241999


Description:

NebuSelect™ Recombinant Human TNFRSF12A/TWEAKR, hFc-tag(Cat#NBL-241999) is expressed in HEK293 with hFc tag at the N-Terminus.It contains Glu28-Per80.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 32.9 kDa. Due to glycosylation, the protein migrates to 38-45 kDa based on Bis-Tris PAGE result.


Target Name:

TNFRSF12A/TWEAKR; FGF-inducible 14; Fgfrp2; TNFRSF12A; FN14; CD266; TWEAKR


Target Information:

Thyroid cancer (TC) is the most well-known endocrine neoplasia as well as a common malignant tumor in the head and neck.TNFRSF12A expression may be a potential useful prognostic molecular biomarker of bad survival in thyroid cancer, in addition, PPAR signaling pathway, insulin signaling pathway, mTOR signaling pathway may be the key pathway controlled by TNFRSF12A in thyroid cancer. Further experimental ought to be performed to demonstrate the biologic effect of TNFRSF12A.


Amino Acid Sequence: 

Glu28-Per80


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品